8572
ENTEROFLEGIN 30 TABLETS
ENTEROFLEGIN 30 TABLETS
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
ENTEROPHLEGIN
Food supplement based on HBQ-complex (complex containing Hericium, Berberis titrated in berberine and quercetin), niacin and biotin.
Biotin and niacin contribute to normal energy-yielding metabolism and the maintenance of normal mucous membranes. Berberis contributes to regular intestinal transit and digestive system function.
Ingredients
HBQ-complex {Hericium [Hericium erinaceus (Bull.) Pers., sporophorum] powder tit. 5% in polysaccharides, Hericium [Hericium erinaceus (Bull.) Pers., sporophorum] es tit.30% polysaccharides, Berberis (Berberis vulgaris L., cortex ex Radicibus) es tit. 97% berberine, quercetin 98%}; bulking agents: microcrystalline cellulose, hydroxypropyl methylcellulose, calcium carbonate; anti-caking agents: mono and diglycerides of fatty acids, silicon dioxide (nano), magnesium salts of fatty acids, enteric coating (water; glazing agent: ethylcellulose; ammonium hydroxide; emulsifier: mono and diglycerides of fatty acids; anti-caking agents: sodium carboxymethylcellulose, talc; stabilizer: polydextrose), niacin (nicotinamide), biotin (D-biotin).
Gluten free.
Naturally free of
lactose.
Nutritional characteristics
| Average values | per 1 tablet | for 2 tablets |
| Hericium erinaceus powder tit. 5% polysaccharides | 525 mg | 1,050 mg |
| Hericium erinaceus tit. 30% polysaccharides | 225 mg | 450 mg |
| Total polysaccharides | 93.75 mg | 187.5 mg |
| Quercetin 98% | 75 mg | 150 mg |
| Biotin | 225 mcg (450% VNR*) |
450 mcg (900% VNR*) |
| Niacin | 27 mg (168.75% VNR*) |
54 mg (337.5% VNR*) |
| Berberis vulgaris is tit. 97% berberine | 75 mg | 150 mg |
How to use
We recommend taking 1 or 2 tablets per day, accompanied by a glass of water.
Warnings
Keep out of reach of children under 3 years of age to avoid accidental ingestion. Do not exceed the recommended daily dose. Supplements should not be used as a substitute for a varied, balanced diet and a healthy lifestyle. Do not use the product if the packaging is damaged. Use is not recommended in cases of known hypersensitivity to one or more of the listed ingredients. Given the nature of the ingredients, the product may vary in appearance from batch to batch; this does not affect the quality of the product. Do not exceed the recommended daily dose. For use of the product by pregnant or breastfeeding women and children, it is recommended to consult a doctor.
Conservation
Store in a dry place at a temperature between 12°C and 25°C (RH<50%). Avoid exposure to localized heat sources and sunlight. The minimum shelf life refers to the product when stored properly and in its original packaging. Store the product in its original packaging. Do not store the product near hazardous substances, such as ammonia, gasoline, acetone, or easily evaporating or flammable substances.
Format
30 tablets of 1,440 mg.
Net weight: 43.2 g.
8572
ENTEROFLEGIN 30 TABLETS
ENTEROFLEGIN 30 TABLETS
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
